2022Ä꣬£¬£¬£¬£¬ÑۿƾµäÔÓÖ¾¡¶Cornea¡·»ØÊ×·¢Ã÷£¬£¬£¬£¬£¬±»Òý´ÎÊý×î¶àµÄʵÑéÐÔÑо¿ÊÇ1995ÄêÉúÎïÑòĤ£¨Ì¥ÅÌÄÚ°ü¹üÑòË®µÄ±¡Ä¤£©ÓÃÓÚÑÛ±íÖØÐÞµÄÂÛÎÄ¡£¡£¡£¡£³ýÑÛ¿ÆÍ⣬£¬£¬£¬£¬ÑòĤ¿ÉÓ¦ÓÃÓÚÍâÉËÐÞ¸´¡¢¹Ç¿ÆµÈÁìÓò£¬£¬£¬£¬£¬¿°³ÆÍò½ðÓÍ¡£¡£¡£¡£È»¶ø£¬£¬£¬£¬£¬ÉúÎïÑòĤÔÚÁÙÅèºóͨ³£±»¿´³ÉÒ½ÁÆ·ÏÎïÏú»Ù¡£¡£¡£¡£ÕâÑùÒ»¸öÒ½ÁÆ·ÏÎ£¬£¬£¬£¬ÊÇÔõÑùÄæÏ®µÇÉÏÊÖÊǫ̃£¬£¬£¬£¬£¬³ÉΪ×îÊÜÖõÄ¿µÄÔÙÉúÖÊÁÏ£¿£¿
´Ó»ùµ×Ĥ¡¢Ó²ÄÔĤµ½Ò»Ð©Ö÷ÒªÆ÷¹Ù£¬£¬£¬£¬£¬Ä¤ÆÕ±é±£´æÓÚÈËÌå¡£¡£¡£¡£×ÔȻĤÖÊÁϾ߱¸¸ß¶ÈµÄÉúÎïÏàÈÝÐԺʹó×Ú»îÐÔÒò×Ó£¬£¬£¬£¬£¬³ýÁ˸ôÀë·À»¤×÷Ó㬣¬£¬£¬£¬»¹¿ÉÒÔ×÷ΪÔÙÉúÖÊÁÏ¡£¡£¡£¡£
ÒÑÍùÒ»°ÙÄêÖУ¬£¬£¬£¬£¬ÈËÀàʵÑé°ÑÖÖÖÖÉúÎïĤÓÃ×÷ÐÞ¸´ÔÙÉú£¬£¬£¬£¬£¬´ÓƤ·ô¡¢½ÇĤµ½¿ÚÇ»£¬£¬£¬£¬£¬´ÓÈËÌåµ½ÖíС³¦ð¤Ä¤¡¢Ð¡Å£ÕæÆ¤ÉõÖÁ¼¦µ°Ä¤¡£¡£¡£¡£ÖîÈçÖíϲãð¤Ä¤µÈ×ÔȻĤÒѱ»ÓÃ×÷ðÞ²¹Æ¬¡¢Ó²ÄÔĤ¡¢¿ÚǻĤµÈ£¬£¬£¬£¬£¬ÔÐÓýÁËÕýº£ÉúÎï¡¢¹Úê»ÉúÎïµÈÉÏÊй«Ë¾¡£¡£¡£¡£
ÔÚ×ÔȻĤÖÊÁÏÖУ¬£¬£¬£¬£¬ÉúÎïÑòĤÊÇΨһ¸ôÀëÁ½Ð¡ÎÒ˽¼ÒµÄÈËÌå×éÖ¯¡£¡£¡£¡£ÑòĤÒò°ü¹üÑòË®¶øµÃÃû£¬£¬£¬£¬£¬ÊÇÌ¥ÅÌ×îÄÚ²¿µÄ͸Ã÷±¡Ä¤£¬£¬£¬£¬£¬ÓëÌ¥¶ùÖ±½Ó½Ó´¥¡£¡£¡£¡£ÑòĤ´Óϸ°û×ÌÑø²ãÑÝ»¯¶øÀ´£¬£¬£¬£¬£¬¸ôÀëÁËÔи¾ÓëÌ¥¶ù£¬£¬£¬£¬£¬²¢ÇÒÖ§³ÖÌ¥¶ùµÄ·¢Óý£¬£¬£¬£¬£¬¾ß±¸×ÔÈ»µÄ¸ßÉúÎïÏàÈÝÐÔÓë¶à»îÐÔÒò×Ó¡£¡£¡£¡£
ÑòĤµÄÔÙÉúҽѧDZÁ¦ÔÚ20ÊÀ¼Í³õ¼´±»¾ò¿Í¡£¡£¡£¡£1910Ä꣬£¬£¬£¬£¬Davis µÚÒ»´Î±¨µÀÁËÓòú¸¾ÑòĤ×÷ΪÍâ¿ÆÆ¤·ôÒÆÖ²µÄÖÊÁÏ£»£»£»£»£»ËæºóÑòĤÔÚÆ¤·ôÉÕÉËºÍÆ¤·ôÀ£ÑñµÄÖÎÁÆ¡¢È˹¤ÒõµÀÖÊÁÏ¡¢½ÇĤ֨ÐÞµÄÓ¦Óþù»ñµÃÀֳɡ£¡£¡£¡£½üÎåÄêµÄÁÙ´²ÊÔÑéÖУ¬£¬£¬£¬£¬ÑòĤ˳Ӧ֢¼¯ÖÐÔÚÍâÉËÐÞ¸´¡¢¹Ç¿Æ¼°ÑÛ¿ÆÁìÓò£¬£¬£¬£¬£¬ÒÑÓÐÏà¹Ø²úÆ·ÉÏÊУ»£»£»£»£»ÔÚÃÚÄò¿Æ¡¢¿ÚÇ»ºÍÖ×ÁöÁìÓòÉÐÊôת»¯½×¶Î¡£¡£¡£¡£Áè¼Ý 50%µÄÁÙ´²Ñо¿ÔÚÃÀ¹úÍê³É£¬£¬£¬£¬£¬ÒÑÓлñÅú²úÆ·¡£¡£¡£¡£½ôËæØÊºóµÄÖйú¡¢°£¼°¡¢Ó¡¶È¡¢ÒÁÀʺ͵¹úÒ²½«Óиü¶à²úÆ·»ñÅú¡£¡£¡£¡£
1.1 ÑÛ¿ÆÓ¦Ó㺴µ¾¡»ÆÉ³Ê¼µ½½ð
1940 Ä꣬£¬£¬£¬£¬De Roth Ê״ν«ÑòĤӦÓÃÓÚÑÛ²¿£¬£¬£¬£¬£¬ÐÞ¸´½áĤȱË𡣡£¡£¡£½Ç½áĤÉÏÆ¤È±Ë𱬷¢ÓÚÉÕÉË¡¢À£Ññ¡¢Òí×´æÀÈâÊõºó¡¢±í²ã½ÇĤÇü¹âÊõºóµÈ¡£¡£¡£¡£¹Å°åµÄÑÛ±íÖØÐÞ½ÓÄÉļ¾èȪԴµÄ½ÇĤºÍ×ÔÌå½áÄ¤ÒÆÖ²£¬£¬£¬£¬£¬±£´æ½ÇĤ¹©Ìå½ôȱºÍ×ÔÌå½áĤÔì³ÉÒ½Ô´ÐÔËðÉ˵ÈÎÊÌâ¡£¡£¡£¡£
ÒÀ¾Ý¾µäµÄ¡°XYZ¼Ù˵¡±£¬£¬£¬£¬£¬ÑÛÇòĤµÄÍêÕûÒÀÀµÓÚÔÙÉúÆøÖÆ£¬£¬£¬£¬£¬´ó×ÚÉÏÆ¤Ï¸°ûµÄËðʧÓë¿ìËÙÔÙÉú¸æ¿¢Æ½ºâ¡£¡£¡£¡£µ±·ºÆð×é֯ȱËð¡¢½ÇĤԵ¸Éϸ°ûÒ쳣ʱ£¬£¬£¬£¬£¬ÑÛÇòµÄÔÙÉúÆøÖÆÄÑÒÔΪ¼Ì¡£¡£¡£¡£Òò´Ë£¬£¬£¬£¬£¬ÑÛÇòĤµÄÐÞ¸´¶ÔÖ¤ÁϵÄÒªÇ󼫸ߡ£¡£¡£¡£
De RothʵÑéÁËÖÖÖÖ×ÔȻĤÖÊÁϺ󣬣¬£¬£¬£¬·¢Ã÷ÑòĤ¿ÉÄÜÊÇΨһµÄÀíÏëÔÙÉúÖÊÁÏ£º£¨1£© Ƥ·ô£ºÓ²ÖÊ¡¢¾ßÓÐÑÕÉ«£»£»£»£»£»£¨2£©¿ÚÇ»ð¤Ä¤£ººìÉ«¡¢³ß´çÓÐÏÞ£»£»£»£»£»£¨3£©ÒõµÀð¤Ä¤£ºÑéÖ¤ÓÐÓ㬣¬£¬£¬£¬µ«¿ÉÄÜ»áÒÆÖ²ºóËõ¶Ì£»£»£»£»£»£¨4£©°üƤ£ºÐ§¹ûºÃ£¬£¬£¬£¬£¬µ«»¼Õ߾ܾø´ÓÔÆÔÆÅ³ÈõµÄµØ·½ÒÆÖ²¡£¡£¡£¡£
¶øÑòĤ¾ß±¸±¡¡¢Æ½»¬¡¢Í¸Ã÷¡¢ÎÞѪ¹ÜµÈÌØµã£¬£¬£¬£¬£¬Óë½áĤ×îΪÏàËÆ£¬£¬£¬£¬£¬²¢¿ÉÒÔ´ó×Ú»ñµÃ¡£¡£¡£¡£De Roth½«ÑòĤӦÓÃÔÚÁË8̨ÊÖÊõÖУ¬£¬£¬£¬£¬Ð§¹ûÏÔʾÔÚÑòĤ±»ÎüÊպ󣬣¬£¬£¬£¬ÔȱËðÇøÓòÏñÕý³£½ÇĤһÑù¡£¡£¡£¡£
ÔÚ´ËÖ®ºó£¬£¬£¬£¬£¬×îÏÈÁËÑòĤÔÚÑÛ¿ÆÓ¦ÓÃµÄÆÕ±éʵÑé¡£¡£¡£¡£µ«ÓÉÓÚÊìϤ²»Ç壬£¬£¬£¬£¬´ó×ÚÑо¿»ìÓÃÁË̥Ĥ¡¢ÈÞëĤ£¨ÑòĤÃâÒßÔÐÔµÄÖ÷ҪȪԴ£©¡¢ÑòĤ£¬£¬£¬£¬£¬µ¼ÖÂÑо¿Ð§¹ûÁ¼Ý¬²»Æë£¬£¬£¬£¬£¬ÑòĤ²¢Ã»Óдó¹æÄ£ÆÌ¿ªÊ¹Óᣡ£¡£¡£Ö±µ½1995Ä꣬£¬£¬£¬£¬KimºÍTsengÀֳɵØÊ¹ÓÃÑòĤ¶Ô½ÇĤ¼°½ÇĤԵ¸Éϸ°ûȱËðµÄÍÃ×Ó¾ÙÐÐÒÆÖ²£¬£¬£¬£¬£¬Ïà¹ØÐ§¹û½ÒÏþÓÚÑۿƾµäÔÓÖ¾¡¶Cornea¡·£¬£¬£¬£¬£¬ÔÙ¶ÈÒý·¢Èȳ±¡£¡£¡£¡£
ÔÚ2022Äê¡¶Cornea¡·»ØÊ×ÖÐÌá¼°£¬£¬£¬£¬£¬KimºÍTsengµÄÕâÆªÉúÎïÑòĤÎÄÕ³ÉΪÁ˱»Òý´ÎÊý×î¶àµÄʵÑéÐÔÑо¿¡¢ÒÔ¼°±»Òý´ÎÊýµÚ¶þ¶àµÄ½ÇĤÎÄÏס£¡£¡£¡£
ÁÙ´²Êµ¼ùÖУ¬£¬£¬£¬£¬ÉúÎïÑòĤ¿ÉÓÃÓÚÒí×´æÀÈâ¡¢½ÇĤÉÏÆ¤È±Ëð¡¢Çà¹âÑÛµÈÊÖÊõ¡£¡£¡£¡£¿ÉÒÔ˵¹Å°åµÄÒÆÖ²ÊÖÊõ¾ù¿ÉÓÃÑòÄ¤Ìæ»»»òÁªÓᣡ£¡£¡£
ÌØÊâÊÇÒí×´æÀÈ⣬£¬£¬£¬£¬º£ÄÚÄêÊÖÊõÁ¿¸ß´ï150Íǫ̀£¬£¬£¬£¬£¬Í¨³£Ðд¿´âÇгýÊõ£¬£¬£¬£¬£¬Ô¼Ò»°ë»¼Õ߻Ḵ·¢£»£»£»£»£»¶øÁªºÏÑòÄ¤ÒÆÖ²Êõ+Ë¿ÁÑÃ¹ËØCºó£¬£¬£¬£¬£¬¸´·¢ÂʿɽµÖÁ5.8%¡£¡£¡£¡£²¿·ÖÑо¿ÏÔʾ¸´·¢ÂÊÂÔ¸ßÓÚ×ÔÌå½áÄ¤ÒÆÖ²Êõ£¬£¬£¬£¬£¬µ«µ±È±ËðÃæ»ý½Ï´óʱ£¬£¬£¬£¬£¬ÑòÄ¤ÒÆÖ²×èÖ¹ÁË´óÃæ»ýÈ¡ÓýáĤÔì³ÉµÄÒ½Ô´ÐÔËðÉË£¬£¬£¬£¬£¬ïÔÌñ£ºÛ»¯¡£¡£¡£¡£²¢ÇÒæÀÈâÇгýÊõºó£¬£¬£¬£¬£¬ÁªºÏ×ÔÌå½áÄ¤ÒÆÖ²¡¢ÑòÄ¤ÒÆÖ²£¬£¬£¬£¬£¬¿É½µµÍÊõºóÑ×Ö¢¼¸ÂÊ£¬£¬£¬£¬£¬½øÒ»²½½µµÍ¸´·¢ÂÊ¡£¡£¡£¡£
ÉúÎïÑòĤҲ¿ÉÓÃÓÚÇà¹âÑÛÂ˹ýÊõºó£¬£¬£¬£¬£¬ÓÃÀ´ÒÖÖÆñ£ºÛÐγɡ£¡£¡£¡£È«ÇòÇà¹âÑÛ»¼²¡ÈËȺÖУ¬£¬£¬£¬£¬Ô¼ËÄ·ÖÖ®Ò»µÄ»¼ÕßÀ´×ÔÖйú£¬£¬£¬£¬£¬2020Äê´ï2100Íò£¬£¬£¬£¬£¬ÖÂîÕßÊýµÖ´ï567Íò¡£¡£¡£¡£Çà¹âÑÛ³£ÓÃÊõʽΪͨÀýСÁºÇгýÊõ£¬£¬£¬£¬£¬ÀÖ³ÉÂʽöΪ11%~52%¡£¡£¡£¡£½áĤÏÂÂ˹ýÅÝñ£ºÛ»¯Êǵ¼ÖÂÇà¹âÂ˹ýÊÖÊõʧ°ÜµÄÖ÷ÒªÔµ¹ÊÔÓÉ£¬£¬£¬£¬£¬»¼ÕßÍùÍùÐèÒªÖØ¸´ÊÖÊõ¡£¡£¡£¡£ÁªºÏÑòÄ¤ÒÆÖ²Êõ£¬£¬£¬£¬£¬½«ÑòĤÖÃÓÚ½áĤ±ßÑØ¡¢¹®Ä¤°êÏ£¬£¬£¬£¬£¬¿ÉʹÓÃÑòĤµÄ¿¹ÏËά»¯ÌØÕ÷¸ÄÉÆÔ¤ºó¡£¡£¡£¡£
1.2 ÆäËûѧ¿Æ£ºÖ±¹ÒÔÆ·«¼Ã²×º£
ÍâÉËÐÞ¸´ºÍ¹Ç¿ÆÊÇÉúÎïÑòĤÂÊÏÈÉÌÒµ»¯µÄÁìÓò¡£¡£¡£¡£´óÃæ»ýÉî¶ÈÉÕÉË¡¢ÄÑÓúÐÔÀ£ÑñÈçÌÇÄò²¡×ãÀ£ÑñµÈÐÞ¸´ÄÑÌ⣬£¬£¬£¬£¬¾ù¿ÉÓ¦ÓÃÉúÎïÑòĤ£¬£¬£¬£¬£¬´Ùѧϰ¸´£¬£¬£¬£¬£¬ÒÖÖÆñ£ºÛ±¬·¢¡£¡£¡£¡£
ÉúÎïÑòĤÔÚÌåÄÚÍâͬÑù±»Ö¤Êµ¾ßÓÐÐÞ¸´¹ÇȱËð¡¢Èí¹ÇËðÉ˺ͼ¡ëìËðÉ˵ÄÄÜÁ¦¡£¡£¡£¡£¼¡ëìËðÉËÐÞ¸´ÖУ¬£¬£¬£¬£¬ËðÉ˲¿Î»·ìºÏºó°ü¹üÑòĤ£¬£¬£¬£¬£¬¿ÉÏÔןÄÉÆ¾Ö²¿ð¤Á¬£¬£¬£¬£¬£¬Ôö½ø¼¡ë콺ÔÏËάºÏ³É£¬£¬£¬£¬£¬Ëõ¶ÌÐÞ¸´Ê±¼ä£¬£¬£¬£¬£¬¼¡ëì³ÐÔØÁ¦ÏÔ×ÅÓÅÓÚͨÀý·ìºÏ¡£¡£¡£¡£
¹ÄĤ´©¿×ÖУ¬£¬£¬£¬£¬¶úÄÚ¾µÏßÏÂÉúÎïÑòÄ¤ÒÆÖ²ÐйÄĤ´©¿×ÐÞ²¹Êõ£¬£¬£¬£¬£¬×èÖ¹×ÔÌåÈ¡²Ä´´ÉËÓëñ£ºÛ£¬£¬£¬£¬£¬¾ßÓÐÊÖÊõ¶Ì£¬£¬£¬£¬£¬³öѪÉÙµÈÓŵ㡣¡£¡£¡£ÆäËûÁìÓòÈç±ÇÀá¹ÜÖØÐÞ¡¢Éñ¾ÎǺÏÐÞ¸´¡¢×Ó¹¬ÄÚĤÐÞ¸´µÈ¾ù¿ÉÓ¦ÓÃÑòĤ¡£¡£¡£¡£
ÑòĤÊÇÈËÌå×îºñµÄĤ֮һ£¬£¬£¬£¬£¬ÊÇÒ»ÖÖÎÞÉñ¾¡¢¼¡ÈâºÍÁܰ͹ܵİë͸Ã÷Ĥ״×éÖ¯£¬£¬£¬£¬£¬Ö÷ÒªÓÉÑòĤÉÏÆ¤Ï¸°û¡¢ÑòĤ¼ä³äÖʸÉϸ°ûºÍ³ÉÏËάϸ°û×é³É¡£¡£¡£¡£ÑòĤ×ÔÍâÏòÄÚ£¬£¬£¬£¬£¬¿É·ÖΪÉÏÆ¤Ï¸°û²ã¡¢»ùµ×Ĥ¡¢ÖÂÃܲ㡢ÏËάϸ°û²ã¼°º£Ãà²ãÎå¸ö²¿·Ö¡£¡£¡£¡£
͸Ã÷¡¢ÎÞѪ¹ÜʹÑòĤÊʺÏÒÆÖ²£»£»£»£»£»¸»ºñµÄ½ºÔÏËά°ü¹ÜÁË¿¹ÀÁ¦£»£»£»£»£»»ùµ×²ã¸»ºñµÄ°ëÇÅÁ£ÒÔ¼°ÖØ´óµÄ½ºÔÍøÂçʹÉÏÆ¤Ï¸°ûÒ×ÓÚÉú³¤¼°Õ³¸½£»£»£»£»£»ÑòĤÍâòµÄÃÔ·¹ÜµÀϵͳʹÆäÒ×ÓÚ¾ÙÐÐÎïÖʽ»Á÷£»£»£»£»£»×÷ΪͬÖÖÒìÌåÖÊÁÏ£¬£¬£¬£¬£¬²»±í´ïHLA-A,B,C£¬£¬£¬£¬£¬DR£¬£¬£¬£¬£¬¿¹ÔÐÔ¼«µÍ£¬£¬£¬£¬£¬¿É×èÖ¹ÃâÒßÇãÔþ·´Ó¦¡£¡£¡£¡£
ÓÉÓÚÆæÒìµÄ×é֯ѧ½á¹¹¡¢·±¶àµÄ»îÐÔÒò×Ó£¬£¬£¬£¬£¬ÑòĤÄܹ»Ôö½øÉÏÆ¤Ðγɣ¬£¬£¬£¬£¬ÒÖÖÆÑ×Ö¢ºÍÐÂÉúѪ¹Ü¡¢ÒÖÖÆÏËά»¯¡£¡£¡£¡£
×éÖ¯¹¤³ÌÊÖÒÕ°üÀ¨3¸öÒªËØ£¬£¬£¬£¬£¬¼´Éú³¤Òò×Ó¡¢ÖÖ×Óϸ°ûºÍÖ§¼ÜÖÊÁÏ¡£¡£¡£¡£ÔÚϸ°û²ãÃæ£¬£¬£¬£¬£¬ÑòĤ¸»º¬ÑòĤÉÏÆ¤¸Éϸ°û£¨AEC£©ºÍÑòĤ¼ä³äÖʸÉϸ°û£¨AMSCs£©£¬£¬£¬£¬£¬ÕâЩϸ°û¾ßÓи߶ȿÉËÜÐÔ£¬£¬£¬£¬£¬ÏÔʾ¶àÏò·Ö½âDZÄÜ£¬£¬£¬£¬£¬²¢ÇÒÔÚÒÆÖ²ºóûÓÐÖÂÁöΣº¦¡£¡£¡£¡£¼ÓÖ®¸»ºñµÄϸ°ûÒò×Ó£¬£¬£¬£¬£¬ÆæÒìµÄ×éÖ¯½á¹¹£¬£¬£¬£¬£¬ÑòĤÊÇÀíÏëµÄÔÙÉúÖÊÁÏ¡£¡£¡£¡£
3.1 ÉÌÆ·ÑòĤ£º×·ÇóÌù½üÐÂÏÊ״̬µÄ´¦Öóͷ£·½·¨
ÉúÎïÑòĤȡ×Ô¾èÔùµÄÌ¥ÅÌ£¬£¬£¬£¬£¬ÆÊ¹¬²úºó½«ÑòĤ´ÓÈÞëĤÉÏÊèÉ¢£¬£¬£¬£¬£¬¾Ï´åª¡¢Ãð¾ú£¬£¬£¬£¬£¬¿ÉµÃÐÂÏÊÑòĤ¡£¡£¡£¡£ÐÂÏÊ£¨»òÀ䲨£©ÑòĤÄܹ»×îºéÁ÷ƽ±£´æÖÖÖÖ×ÔÈ»½ºÔ¼°»îÐÔÒò×ÓÒòËØ£¬£¬£¬£¬£¬Òò´ËÁÙ´²Ê¹ÓÃЧ¹û½ÏºÃ¡£¡£¡£¡£
ÔºÄÚ×ÔÖÆÑòĤÓÉÓÚÃð»î·½·¨¼òÆÓ£¬£¬£¬£¬£¬ÇÒȱÉÙÖʼ첽·¥£¬£¬£¬£¬£¬ÁÙ´²Ê¹Óñ£´æÑ¬È¾Î£º¦¡£¡£¡£¡£ÁÙ´²Ø½ÐèÌù½üÐÂÏÊÑòĤ¡¢¸üÇå¾²¡¢±ê×¼»¯µÄÑòĤÉÌÆ·£¬£¬£¬£¬£¬ÌôÕ½Ö÷ÒªÀ´×ÔÓÚÈ·±£Ãð¾ú¡¢Ìù½üÐÂÏÊ״̬µÄ´¦Öóͷ£ºÍÖü´æÊÖÒÕ¡£¡£¡£¡£
ÏÖÔÚÑòĤµÄÖü´æÒªÁìÖ÷Òª°üÀ¨¶³¸ÉºÍÀä¶³ÉúÑÄ¡£¡£¡£¡£¶³¸ÉÊǽ«ÑòĤÔÚÔÚ -50ÖÁ-80¡ãCÏ¿ìËÙÀä¶³£¬£¬£¬£¬£¬È»ºóʹÓÃÀä¶³¸ÉÔï»úÔÚ¸ßÕæ¿ÕϸÉÔï¡£¡£¡£¡£Í¨¹ýÉý»ªÌáÈ¡×éÖ¯Öб£´æµÄË®£¬£¬£¬£¬£¬ÒÔ½«Ë®º¬Á¿½µµÍÖÁ5-10%¡£¡£¡£¡£Àä¶³ÉúÑÄÊǽ«ÑòĤÉúÑÄÔÚDMEM©U¸ÊÓͰ´1£º1±ÈÀýÅäÖÆµÄÉúÑÄÒºÖУ¬£¬£¬£¬£¬²¢ÓÚ-80¡æ±ùÏäÖж³´æ£¬£¬£¬£¬£¬ÓÐÓÃÆÚΪ1ÖÁ2Äê¡£¡£¡£¡£
¶³¸ÉÑòĤËäÈ»¾ßÓÐÊÒÎÂÖü´æºÍÔËÊäµÄÓÅÊÆ£¬£¬£¬£¬£¬ÓÉÓÚ¶³¸É¡¢ÍÑϸ°ûµÈ¹¤ÒÕÓ°Ï죬£¬£¬£¬£¬ÁÙ´²Ð§¹ûÓëÐÂÏÊÑòĤ²îÖ®ÉõÔ¶¡£¡£¡£¡£²»µ«ËðʧÁË´ó×ÚÓÐÓÃÒòËØ£¬£¬£¬£¬£¬»¹ÈÝÒ×Ôì³ÉÂѰ×ÖʱäÐÔ¡¢ÑòĤÖÖÖÖÀí»¯ÐÔÄܽµµÍ£¬£¬£¬£¬£¬Ö±½Óµ¼ÖÂÑòĤÔÚÊÖÊõÖÐÒ×˺ÁÑ£¬£¬£¬£¬£¬ÐèÒªÖØ¸´Ìæ»»£¬£¬£¬£¬£¬ÑÓÉìÊÖÊõʱ¼ä£»£»£»£»£»ÊõºóÑ×Ö¢·´Ó¦Ç¿ÁÒ£¬£¬£¬£¬£¬ÑòĤÈÝÒ׿ìËÙ½µ½â¡¢ÍÑÂä¡£¡£¡£¡£Òò´Ë¶³¸ÉÑòĤÖ÷ÒªÓ¦ÓÃÓÚ¶Ô»îÐÔÒò×Ó¡¢×éÖ¯½á¹¹ÒªÇó½ÏµÍµÄÉË¿ÚÕչ˻¤Ê¿¡¢¹Ç¿ÆÁìÓò£¬£¬£¬£¬£¬ÉÌÆ·»¯ÑòĤ¹«Ë¾ÒÔMIMEDX£¨NASDAQ:MDXG)£©Îª´ú±í£¬£¬£¬£¬£¬º£ÄÚÒÔÈð¼ÃÉúÎïΪÖ÷¡£¡£¡£¡£
Àä¶³ÉúÑĵÄÉÌÆ·ÑòĤÒÔTissueTechΪ´ú±í£¬£¬£¬£¬£¬µ«ÓÉÓÚºã¾ÃÉîµÍÎÂÉúÑı¾Ç®½Ï¸ß£¬£¬£¬£¬£¬²¢ÇÒÆä¹¤ÒÕδ¶ÔÑòĤ¾ÙÐÐÃð¾úºÍ²¡¶¾Ãð»î´¦Öóͷ££¬£¬£¬£¬£¬ÎÞ·¨´ó¹æÄ£Íƹ㡣¡£¡£¡£ÑÛ¿ÆÁìÓò£¬£¬£¬£¬£¬ÃÀ¹úÈÔÒÔ×ÔÖÆÑòĤΪÖ÷¡£¡£¡£¡£
3.2 ÁÙ´²Êг¡£¡£¡£¡£ºØ½ÐèÁ¢Òì²úÆ·ÆÆ¾Ö
¾ÝApollo Research Reportsµ÷ÑУ¬£¬£¬£¬£¬2022ÄêÈ«ÇòÉúÎïÑòĤÊг¡¹æÄ£µÖ´ï32.6ÒÚÃÀÔª¡£¡£¡£¡£Ö÷ÒªÓ¦ÓÃÓÚÉË¿ÚÐÞ¸´¡¢¹Ç¿Æ¼°ÑÛ¿Æ¡£¡£¡£¡£Î´À´ÑòĤ×÷Ϊ¸ßÐÔÄÜÔÙÉúҽѧÖÊÁÏ¿ÉÍØÕ¹ÖÁÊýÊ®¸öÁìÓò£¬£¬£¬£¬£¬»Ý¼°ÒÚÍò»¼Õß¡£¡£¡£¡£
ÊÂʵÉÏ£¬£¬£¬£¬£¬Ö»¹ÜÁÙ´²Ö¤¾Ý¸»×㣬£¬£¬£¬£¬ÊÜÏÞÓÚ¶³¸ÉÑòĤµÄÁÓÊÆ£¬£¬£¬£¬£¬ÑòĤÊÖÊõÉøÍ¸ÂÊÈÔÈ»¼«µÍ¡£¡£¡£¡£²¢ÇÒ£¬£¬£¬£¬£¬ÏÖÓÐÑòĤÊÖÊõÈÔ´ó×ÚʹÓÃÔºÄÚ×ÔÐаþÖÆµÄÐÂÏÊÑòĤ»ò¸ÊÓÍÉúÑÄÑòĤ¡£¡£¡£¡£
ÔÚÃÀ¹ú£¬£¬£¬£¬£¬×Ô 2000 ÄêÒÔÀ´£¬£¬£¬£¬£¬¾Ý¡¶¹«¹²ÎÀÉúЧÀÍ·¨¡·µÚ361ÌõÌõ¿î£¬£¬£¬£¬£¬Õë¶Ô×ÔÌåȪԴ¡¢×îС»¯´¦Öóͷ£ºÍͬԴʹÓõÄ×é֯ϸ°û²úÆ·£¨HCT / P£©£¬£¬£¬£¬£¬ÎÞÐèÉÏÊÐÉóÅú£¬£¬£¬£¬£¬½öÐ豸°¸¡£¡£¡£¡£·ÇͬԴʹÓõÄ×é֯ϸ°û²úÆ·£¬£¬£¬£¬£¬ÔòÊÊÓõÚ351Ìõ£¬£¬£¬£¬£¬Æ¾Ö¤Ò½ÁƺIJľÙÐÐÁÙ´²ÊÔÑé¡£¡£¡£¡£ÑòĤ²úÆ·Ó¦ÓÃÓÚÑÛ±í£¬£¬£¬£¬£¬Ê¹ÓÃÑòĤºÍÑÛÇòĤµÄ¸ß¶ÈÏàËÆÐÔ±¬·¢×÷Ó㬣¬£¬£¬£¬ÊôÓÚͬԴÓÃ;£¬£¬£¬£¬£¬ÎÞÐèÉóÅú¡£¡£¡£¡£¶øÓÃÓÚÉË¿ÚÐÞ¸´¡¢¹Ç¿Æ£¬£¬£¬£¬£¬¸ü¶àʹÓõÄÊÇÑòĤ»îÐÔÒò×Ó¶ø²»ÊÇ×éÖ¯½á¹¹×Ô¼º£¬£¬£¬£¬£¬Òò´Ë²»ÊôÓÚͬԴÓÃ;¡£¡£¡£¡£
FDAµÄÉóÅú¿íÃ⣬£¬£¬£¬£¬µ¼ÖÂÁ˸߶ÈÊèÉ¢µÄÑÛ¿ÆÓÃÑòĤÊг¡£¬£¬£¬£¬£¬FDA¹ÒºÅµÄÑòĤ²úÆ·¸ß´ï930ÖÖ¡£¡£¡£¡£Òò´Ë£¬£¬£¬£¬£¬ÉË¿ÚÐÞ¸´¡¢¹Ç¿Æ³ÉΪMIMEDXµÈÍ·²¿¹«Ë¾Öص㷢Á¦µÄÁìÓò¡£¡£¡£¡£MIMEDX²úÆ·Ö÷ÒªÕë¶ÔÌÇÄò²¡×ãÀ£ÑñµÈÄÑÓúºÏÉË¿ÚÐÞ¸´¡¢ÊÖÊõÉË¿ÚÕչ˻¤Ê¿ÒÔ¼°×ãµ×½îĤÑס¢¸úëìÑ׺ÍÏ¥¹ÇÊàŦÑס£¡£¡£¡£
ÑòĤ²úÆ·ÊôÓÚ×éÖ¯ºÍϸ°û²úÆ·£¬£¬£¬£¬£¬ÍâÑó²úÆ·ÎÞ·¨½øÈëÖйú¡£¡£¡£¡£ÔÚÎÒ¹ú£¬£¬£¬£¬£¬2020Äê²ÅÓеÚÒ»¸ö¿¿½üÐÂÏÊ״̬µÄÑòĤÉÌÆ·»ñÅú¡£¡£¡£¡£´Ëǰ£¬£¬£¬£¬£¬º£ÄÚ½öÓж³¸ÉÑòĤ£¬£¬£¬£¬£¬Òò´ËÑòĤÊÖÊõÒÔÔºÄÚ×ÔÖÆÎªÖ÷¡£¡£¡£¡£ÎªÁ˰ü¹ÜÊÖÊõЧ¹û£¬£¬£¬£¬£¬²¿·ÖÒ½ÉúʹÓÃ×ÔÖÆÑòĤ£¬£¬£¬£¬£¬ÐèÒªÔÚÔºÄÚ´¦Öóͷ£Ì¥ÅÌ¡£¡£¡£¡£ÓÉÓÚ×ÔÖÆ²úƷȱ·¦ÊÕ·Ñ·¾¶£¬£¬£¬£¬£¬Ôڼ縺ѬȾΣº¦µÄͬʱ£¬£¬£¬£¬£¬Ò½Éúȱ·¦ÓÐÓü¤Àø£¬£¬£¬£¬£¬ÑòĤÊÖÊõÉøÍ¸ÄÑÌâ¡£¡£¡£¡£
ÑòĤµÄÍÆ¹ã£¬£¬£¬£¬£¬ÊÜÏÞÓÚ¶³¸É¹¤ÒÕ¡£¡£¡£¡£Êг¡Ø½ÐèÁ¢ÒìµÄÉÌÆ·ÑòĤ£¬£¬£¬£¬£¬Íê³ÉÁÙ´²¼ÛÖµÓëÉÌÒµ¼ÛÖµµÄͳһ£º
£¨1£©?ʪ̬ÑòĤ£ºÔÚÇå¾²Ìõ¼þÏ£¬£¬£¬£¬£¬×îºéÁ÷ƽ±£´æÑòĤµÄ×éÖ¯½á¹¹¡¢»îÐÔÒò×Ó£¬£¬£¬£¬£¬½«ÊÇÑòĤ´ó¹æÄ£ÍƹãµÄÖ÷ÒªÌõ¼þ¡£¡£¡£¡£ÌØÊâÊÇÔÚÑÛ¿ÆÁìÓò£¬£¬£¬£¬£¬¶³¸ÉÑòĤÓÐÓÃÐÔÓëÐÂÏÊÑòĤ֧¸¶ÄÑÄæ¾³£¬£¬£¬£¬£¬ÐèÒªÁ¢ÒìµÄʪ̬ÑòÄ¤ÆÆ¾Ö¡£¡£¡£¡£
£¨2£©?ÑòĤ¾µ£ºÉúÎïÑòĤÔÚÑÛ²¿µÄÁÙ´²Ó¦ÓÃÒÀÀµÓÚÊÖÊõ·ìºÏ¡£¡£¡£¡£ÎÞ·ìÏßÀο¿Äܹ»ïÔÌÒ½ÉúµÄÉÏÊÖÄѶȡ¢ïÔÌ·ìÏߴ̼¤¡£¡£¡£¡£ÀàËÆÒþÐÎÑÛ¾µµÄÑòĤ¾µ£¬£¬£¬£¬£¬³ÉΪÃâ·ì¿ÉÅå´øµÄÁ¢Òì¼Æ»®¡£¡£¡£¡£³ýÒí×´æÀÈâÍ⣬£¬£¬£¬£¬ÑòĤ¾µ¿ÉÒÔÓ¦ÓÃÓÚ²»¾ÓÉÇå´´/¼¤¹âÖÎÁƽÇĤÇгýÊõµÄ³¡¾°£¬£¬£¬£¬£¬ÔÚÃÅÕïÍê³ÉÕª´÷¡£¡£¡£¡£Ò»¶¨Ë®Æ½ÉÏÒ²»º½âÁËDRGs/DIPË¢ÐÂÏ£¬£¬£¬£¬£¬×¡ÔºÊÖÊõµÄÖ§¸¶Ñ¹Á¦¡£¡£¡£¡£
£¨3£©?΢·ÛÑòĤ£ºMIMEDXÂÊÏÈ̽Ë÷ÁË΢·ÛÐÎʽµÄÑòĤ£¨AmnioFix Injectable£©¡£¡£¡£¡£ÑòĤ΢·Û¾ÐÄÀíÑÎË®ÅäÖÆ¿É×¢ÉäʹÓ㬣¬£¬£¬£¬Ö÷ÒªÕë¶Ô×ãµ×½îĤÑס¢¸úëìÑ׺͹ÇÊàŦÑס£¡£¡£¡£ÏÖÔÚ½îĤÑ×ÈýÆÚÁÙ´²ÒÑÍê³É£¬£¬£¬£¬£¬¸úëìÑ×½øÈëÈýÆÚÁÙ´²£¬£¬£¬£¬£¬¹ÇÊàŦÑ×Ô¤¼Æ½«ÔÚ2022ÄêÆô¶¯ÈýÆÚÁÙ´²¡£¡£¡£¡£
º£ÄÚÉúÎïÑòĤ´ú±í¹«Ë¾
½¨ÉèÓÚ2014ÄêµÄ¹ãÖÝÈðÌ©ÉúÎïÊÇÒ»¼ÒרעÓÚÑۿƺÍÔÙÉúҽѧµÄÁ¢ÒìÆ÷е¹«Ë¾¡£¡£¡£¡£²úÆ·Ïߺ¸ÇÑÛ±í¡¢Çà¹âÑÛ¡¢Çü¹â²»Õý£¬£¬£¬£¬£¬ÍÚ¾òÑۿƸßÖµºÄ²Äʱ»ú£¬£¬£¬£¬£¬Ìî²¹Êг¡¿Õȱ¡£¡£¡£¡£¹«Ë¾ÓµÓк£ÄÚÊ׸ö»ñÅúÉÏÊеÄÉúÎïʪ̬ÑòĤ£¬£¬£¬£¬£¬Ê¹ÓÃÇå¾²¸ßЧµÄ´¦Öóͷ£¹¤ÒÕÅäºÏ¶À¼Ò¿ª·¢µÄÉúÑÄÒº£¬£¬£¬£¬£¬´òÔì³ö»îÐÔ¿¿½üÐÂÏÊÑòĤµÄÉúÎïÑòĤ£¬£¬£¬£¬£¬ÉúÑÄÓÐÓÃÆÚ³¤´ï3Äê¡£¡£¡£¡£¹«Ë¾´ÓÔÙÉúҽѧÇÐÈ룬£¬£¬£¬£¬´òÔìÑÛ¿ÆÁ¢ÒìÆ÷еƽ̨£¬£¬£¬£¬£¬Ö÷Òª²úÆ·»¹°üÀ¨ÑòĤµü´ú²úÆ·ÑòĤ¾µ¡¢¹®Ä¤¾µ¡¢Çà¹âÑÛ΢֧¼ÜµÈ¡£¡£¡£¡£
½Î÷Èð¼ÃÉúÎÐÂÈý°å£º835940£©½¨ÉèÓÚ2002Ä꣬£¬£¬£¬£¬ÊÇÒ»¼Òפ×ãÓÚÔÙÉúҽѧ¼°ÉúÃü¿µ½¡¹¤Òµ£¬£¬£¬£¬£¬¼¯Éú²ú¡¢Ñз¢¡¢ÏúÊÛΪһÌåµÄ¹ú¼Ò¸ßÐÂÊÖÒÕÆóÒµ¡£¡£¡£¡£Ö÷Òª²úÆ·°üÀ¨Ñۿƶ³¸ÉÑòĤ¡¢¹Ç¿Æ¶³¸ÉÑòĤ¡¢ÑòĤÀáµÀÐÞ¸´Ö§¼ÜµÈ¡£¡£¡£¡£Èð¼ÃÉúÎïÒÔÈËÑòĤΪÒÀÍУ¬£¬£¬£¬£¬Ê¹ÓÃ×ÔÉíǿʢµÄÑз¢ÍŶӣ¬£¬£¬£¬£¬ÁªºÏº£ÄÚ×ÅÃû´óѧ¡¢Ñо¿Ëù¼°Ò½ÔºÏàÖúÍê³ÉÑòĤϵÁвúÆ·µÄÉú²úºÍÑз¢¡£¡£¡£¡£
¹ãÖÝÔÃÇåÔÙÉúҽѧ¿Æ¼¼ÓÐÏÞ¹«Ë¾½¨ÉèÓÚ2015Ä꣬£¬£¬£¬£¬ÊÇÒ»¼Òפ×ãÓÚÑÛ¿ÆÔÙÉúҽѧ£¬£¬£¬£¬£¬ÒÔ½¹µãרÀûÊÖÒÕΪ»ùʯ£¬£¬£¬£¬£¬×¨Òµ´ÓÊÂÑÛ±íÖÎÁƼ°ÐÞ¸´¡¢ÊÓ¹âµ÷½â¡¢¸ÉÑÛµ÷ÀíµÈÖÖÖÖÑÛ¿ÆÒ½ÁÆÆ÷еÑз¢¡¢Éú²ú¼°ÏúÊÛΪһÌåµÄ¸ß¿Æ¼¼ÆóÒµ¡£¡£¡£¡£²úÆ·°üÀ¨ÉúÎï½ÇĤ¡¢ÉúÎïÑòĤ¼°ÑÛ¿ÆÊÖÊõÆ÷е¡£¡£¡£¡£
×ÊÁÏȪԴ£º
1. ĤÉúÎïÖÊÁϼ°ÔÚ×éÖ¯¹¤³ÌÖеÄÓ¦Ó㺡°Ö¸µ¼Ä¤ÔÙÐÄÀíÂÛ¡±µÄÕ¹Íû
2.?Update review on five top clinical applications of human amniotic membrane in regenerative medicine
3.?Transforming ocular surface stem cell research into successful clinical practice
4. ÑòĤÔÚÑÛ¿ÆÁÙ´²ÊÂÇéÖеÄÓ¦ÓÃÏ£Íû
5.?Plastic Repair of Conjunctival Defects with Fetal Membranes
6. Comment on ¡°Cornea Classic Article: Kim JC and Tseng SCG: Transplantation of Preserved Amniotic Membrane for Surface Reconstruction in Severely Damaged Rabbit Corneas¡±
7.?Amniotic Membrane Grafts to Reduce Pterygium Recurrence
8.?Device©\modified trabeculectomy for glaucoma
9.?Õ׿ÆÑÛ¿ÆÕйÉÊé
10.?Recurrent Pterygium: A Review
11.?ÈËÑòĤÔڹǿÆÁìÓòµÄÑо¿Ï£Íû
12.?Applications of the amniotic membrane in tissue engineering and regeneration: the hundred-year challenge
13.?Human Amniotic Membrane: A review on tissue engineering, application, and storage
14. Amniotic membrane in ophthalmology: properties, preparation, storage and indications for grafting¡ªa review
15.??HUMAN CELL AND TISSUE ESTABLISHMENT REGISTRATION
16. Amniotic Membrane and Amniotic Fluid Injections for Non Ophthalmic Applications – CAM 701149
17.? Èð¼ÃÉúÎï¹ÙÍø
18.? ÈðÌ©ÉúÎï¹ÙÍø